Drug Shortage Report for LORAZEPAM INJECTION USP

Last updated on 2018-02-07 History
Report ID 30518
Drug Identification Number 02388669
Brand name LORAZEPAM INJECTION USP
Common or Proper name LORAZEPAM
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LORAZEPAM
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10x1mL GVL
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-12-15
Estimated end date
Actual end date 2018-01-05
Shortage status Resolved
Updated date 2018-02-07
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-02-07 French Compare
v8 2018-02-07 English Compare
v7 2017-12-16 English Compare
v6 2017-12-14 French Compare
v5 2017-12-14 English Compare
v4 2017-12-12 English Compare
v3 2017-11-23 French Compare
v2 2017-11-23 English Compare
v1 2017-11-23 English Compare